Ruian Center of Chinese-American Research Institute for Diabetic Complications, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
School of Pharmaceutical Science, Wenzhou Medical University, Wenzhou, China.
J Diabetes Res. 2021 Jul 7;2021:6662418. doi: 10.1155/2021/6662418. eCollection 2021.
Zinc is an essential trace element that is often reduced under the type 1 diabetic condition. Previous studies demonstrated that zinc deficiency enhanced type 1 diabetes-induced liver injury and that zinc supplementation significantly helped to prevent this. Due to the differences in pathogenesis between type 1 and type 2 diabetes, it is unknown whether zinc supplementation can induce a beneficial effect on type 2 diabetes-induced liver injury. This possible protective mechanism was investigated in the present study. A high-fat diet, along with a one-time dose of streptozotocin, was applied to metallothionein (MT) knockout mice, nuclear factor-erythroid 2-related factor (Nrf) 2 knockout mice, and age-matched wild-type (WT) control mice, in order to induce type 2 diabetes. This was followed by zinc treatment at 5 mg/kg body weight given every other day for 3 months. Global metabolic disorders of both glucose and lipids were unaffected by zinc supplementation. This induced preventive effects on conditions caused by type 2 diabetes like oxidative stress, apoptosis, the subsequent hepatic inflammatory response, fibrosis, hypertrophy, and hepatic dysfunction. Additionally, we also observed that type 2 diabetes reduced hepatic MT expression, while zinc supplementation induced hepatic MT expression. This is a crucial antioxidant. A mechanistic study showed that MT deficiency blocked zinc supplementation-induced hepatic protection under the condition of type 2 diabetes. This suggested that endogenous MT is involved in the hepatic protection of zinc supplementation in type 2 diabetic mice. Furthermore, zinc supplementation-induced hepatic MT increase was unobserved once Nrf2 was deficient, indicating that Nrf2 mediated the upregulation of hepatic MT in response to zinc supplementation. Results of this study indicated that zinc supplementation prevented type 2 diabetes-induced liver injury through the activation of the Nrf2-MT-mediated antioxidative pathway.
锌是一种必需的微量元素,在 1 型糖尿病患者中经常减少。以前的研究表明,锌缺乏会加重 1 型糖尿病引起的肝损伤,而补锌显著有助于预防这种情况。由于 1 型和 2 型糖尿病的发病机制不同,尚不清楚补锌是否会对 2 型糖尿病引起的肝损伤产生有益影响。本研究探讨了这种可能的保护机制。采用高脂肪饮食联合链脲佐菌素一次性给药的方法,构建金属硫蛋白(MT)敲除小鼠、核因子-红细胞 2 相关因子 2(Nrf2)敲除小鼠和同年龄野生型(WT)对照组小鼠,诱导 2 型糖尿病,随后每隔一天给予 5mg/kg 体重的锌治疗,共 3 个月。锌补充并未改变葡萄糖和脂质的全身代谢紊乱。这对 2 型糖尿病引起的氧化应激、细胞凋亡、随后的肝炎症反应、纤维化、肥大和肝功能障碍等情况产生了预防作用。此外,我们还观察到 2 型糖尿病降低了肝 MT 表达,而锌补充诱导了肝 MT 表达。MT 是一种重要的抗氧化剂。一项机制研究表明,在 2 型糖尿病条件下,MT 缺乏会阻断锌补充诱导的肝保护作用。这表明内源性 MT 参与了锌补充对 2 型糖尿病小鼠肝脏的保护作用。此外,一旦 Nrf2 缺乏,锌补充诱导的肝 MT 增加就不会观察到,表明 Nrf2 介导了锌补充对肝 MT 的上调。本研究结果表明,锌补充通过激活 Nrf2-MT 介导的抗氧化途径预防 2 型糖尿病引起的肝损伤。